Else Nutrition CEO to Participate in the Benzinga All Access Event on November 14th
13 Novembro 2023 - 7:36PM
ELSE NUTRITION HOLDINGS INC.
(BABY)
(BABYF)
(0YL.F) ("Else" or the
"Company"), today announced that Hamutal Yitzhak,
CEO of Else Nutrition, will be participating in the Benzinga All
Access event taking place on Tuesday, November 14, 2023.
Ms. Yitzhak is scheduled to appear on Tuesday,
November 14, 2023, at approximately 11:00 AM Eastern Time and plans
to discuss the recent collaboration agreement with Danone as well
as other business developments.
The event will be broadcast live and can be
viewed at
https://www.youtube.com/live/4uVBEOl4qbE?si=sz8mj0o0MWcdefRm. An
archived recording of the presentation will be available on the
investor relations section of the Company’s website at
https://investors.elsenutrition.com/.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX:
BABYF, FSE: 0YL) is a food and nutrition company in the
international expansion stage focused on developing innovative,
clean, and plant-based food and nutrition products for infants,
toddlers, children, and adults. Its revolutionary, plant-based,
non-soy formula is a clean-ingredient alternative to dairy-based
formulas. Since launching its Plant-Based Complete Nutrition for
Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the
brand has received thousands of powerful testimonials and reviews
from parents, gained national retailer support, and achieved rapid
sales growth.
Awards and Recognition:
-
"2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit
-
#1 Best Seller on Amazon in the Fall of 2020 in the New Baby &
Toddler Formula Category
-
“Best Dairy Alternative” Award 2021 at World Plant-Based Expo
-
Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category
-
During September 2022, Else Super Cereal reached the #1 Best Seller
in Baby Cereal across all brands on Amazon
Investor Relations Contact:
Alexandra SchiltCrescendo Communications, LLCOffice: (212)
671-1020 Ext: 305Email: baby@crescendo-ir.com
TSX
Neither the TSX nor its regulation services
provider (as that term is defined in the policies of the TSX)
accept responsibility for the adequacy or accuracy of this
release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute "forward-looking statements" within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as "will" or similar
expressions. Forward-looking statements in this press release
include statements with respect to the anticipated dates for filing
the company's financial disclosure documents. Such forward-looking
statements reflect current estimates, beliefs, and assumptions,
which are based on management's perception of current conditions
and expected future developments, as well as other factors
management believes are appropriate in the circumstances. No
assurance can be given that the foregoing will prove to be correct.
Forward-looking statements made in this press release assume, among
others, the expectation that there will be no interruptions or
supply chain failures as a result of COVID-19 and that the
manufacturing, broker, and supply logistic agreement with the
company does not terminate. Actual results may differ from the
estimates, beliefs, and assumptions expressed or implied in the
forward-looking statements. Readers are cautioned not to place
undue reliance on any forward-looking statements, which reflect
management's expectations only as of the date of this press
release. The company disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
law.
Else Nutrition (TSX:BABY)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Else Nutrition (TSX:BABY)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024